CommBank
CBA
Telstra Group Ltd
TLS
Westpac Banking Corp
WBC
4
Origin Energy Ltd
ORG
5
ANZ Group Holdings Ltd
ANZ
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.120
- 0.0000.00%
20min DelayTrading May 1 14:19 AET
59.08MMarket Cap-5.71P/E (Static)
0.125High0.120Low432.51KVolume0.120Open0.120Pre Close53.30KTurnover0.24552wk High0.12%Turnover Ratio492.31MShares0.09652wk Low-0.021EPS TTM42.16MFloat Cap0.245Historical HighLossP/E (Static)351.37MShs Float0.096Historical Low-0.021EPS LYR4.17%Amplitude--Dividend TTM5.00P/B1Lot Size--Div YieldTTM
Neurizon Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2005 | (FY)Jun 30, 2004 | (FY)Jun 30, 2003 | (FY)Jun 30, 2002 | (FY)Jun 30, 2001 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | 980.62K | 1,069.66%2.87M | -72.41%245.7K | 133.60%890.63K | 381.26K | |
| Revenue from customers | --138.54K | 1,069.66%2.87M | -72.41%245.7K | 133.60%890.63K | --381.26K | ---- |
| Other cash income from operating activities | --842.08K | ---- | ---- | ---- | ---- | ---- |
| Cash paid | -6.17M | -238.48%-4.71M | 4.81%-1.39M | 57.52%-1.46M | 8.92%-3.44M | -3.78M |
| Payments to suppliers for goods and services | ---6.17M | -238.48%-4.71M | 4.81%-1.39M | 57.52%-1.46M | 8.92%-3.44M | ---3.78M |
| Direct interest paid | ---- | 36.55%-29.55K | 61.28%-46.57K | -47.15%-120.28K | -307.30%-81.74K | ---20.07K |
| Direct interest received | --24.47K | 59.34%49.46K | 45.73%31.04K | -77.17%21.3K | -47.90%93.29K | --179.04K |
| Operating cash flow | ---5.17M | -56.52%-1.82M | -73.19%-1.16M | 78.00%-671.07K | 15.77%-3.05M | ---3.62M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -1.17M | -1,248.27%-3.76M | -140.40%-278.91K | 179.49%690.37K | 29.08%-868.49K | -1.22M |
| Net PPE purchase and sale | ---- | -969.89%-3.5M | -2,371.44%-326.77K | 127.50%14.39K | 64.91%-52.31K | ---149.08K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | 59.97%-216.18K | ---540K |
| Net business purchase and sale | ---165.23K | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---1M | -652.28%-264.34K | -92.92%47.86K | 212.66%675.99K | -347.81%-600K | ---133.99K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---401.5K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | ---1.17M | -1,248.27%-3.76M | -140.40%-278.91K | 179.49%690.37K | 29.08%-868.49K | ---1.22M |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 13.34M | 503.30%6.03M | 407.73%999.07K | -111.06%-324.66K | -54.01%2.94M | 6.39M |
| Net issuance payments of debt | ---- | 94.71%-20.82K | 46.94%-393.67K | -3,832.18%-742K | -86.53%19.88K | --147.64K |
| Net common stock issuance | --13.31M | 334.27%6.05M | 233.72%1.39M | -85.69%417.34K | -53.24%2.92M | --6.24M |
| Net other financing activities | --35K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | --13.34M | 503.30%6.03M | 407.73%999.07K | -111.06%-324.66K | -54.01%2.94M | --6.39M |
| Net cash flow | ||||||
| Beginning cash position | --2.71M | -70.80%182.29K | -32.84%624.36K | -51.38%929.71K | --1.91M | ---- |
| Current changes in cash | --7.01M | 201.31%447.87K | -44.77%-442.07K | 68.92%-305.35K | -163.83%-982.37K | --1.54M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | --373.14K |
| End cash Position | --9.71M | 245.69%630.15K | -70.80%182.29K | -32.84%624.36K | -51.38%929.71K | --1.91M |
| Free cash from | ---5.17M | -247.22%-5.32M | -128.11%-1.53M | 79.78%-671.07K | 23.00%-3.32M | ---4.31M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |